Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DNA Script

DNA Script
2014 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$2.7M LATEST DEAL AMOUNT
9 INVESTORS
Description

Developer of a DNA synthesis technology designed to leverage synthesizing DNA and entering the genome-scale synthesis world. The company's technology uses a proprietary template-free enzymatic technology that overcomes the current inefficiencies of synthetic DNA production and provide throughput production of synthetic biology tools, such as oligonucleotides, genes, pathways and genomes, enabling biotechnological and industrial research sectors to accelerate innovation in life science and technology through rapid, affordable and high quality DNA synthesis.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 29 rue du Faubourg Saint
  • Jacques
  • 75014 Paris
  • France
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore DNA Script’s full profile, request a free trial.

DNA Script Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 10-Jul-2018 $2.7M 000.00 Completed Generating Revenue
5. Grant 04-Apr-2018 00.00 000.00 Completed Generating Revenue
4. Grant 01-Feb-2018 00.000 000.00 Completed Startup
3. Early Stage VC (Series A) 12-Sep-2017 000.00 000.00 000.00 Completed Generating Revenue
2. Seed Round 30-May-2016 $2.83M $2.83M 00.000 Completed Generating Revenue
1. Accelerator/Incubator 01-Jul-2015 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

DNA Script Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
ADP 2017 000,000 00.000000 0000.00 0000.00 00 0000.00 00.00
ADP 2016 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 53,489 $0.119193
To view this company’s complete Cap Table, request access »

DNA Script Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bpifrance Sovereign Wealth Fund 000 0000 000000 0
European Commission Government 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Illumina Ventures Venture Capital Minority 000 0000 000000 0
Kurma Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

DNA Script Executive Team (3)

Name Title Board
Seat
Contact
Info
Thomas Ybert Ph.D Co-Founder, Chief Executive Officer & Chairman
Sylvain Gariel Co-Founder, Chief Operating Officer & Board Member
Xavier Godron Co-Founder & Chief Technology Officer

DNA Script Board Members (7)

Name Representing Role Since Contact
Info
Andreas Jurgeit Ph.D Merck Ventures Board Member 000 0000
Heiner Dreismann Ph.D Kurma Partners Board Member 000 0000
Joško Bobanović Ph.D Sofinnova Partners Board Member 000 0000
Nicholas Naclerio Ph.D Illumina Ventures Board Member 000 0000
Philippe Peltier Kurma Partners Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »